These outcomes indicated that knockdown of circASH2L remarkably suppressed tumor progression in vivo, and sh-circASH2L appears to regulate tumorigenesis by inhibiting VEGFA-mediated lymphangiogenesis and angiogenesis. Here, VEGFA is linked to neoplasm.